We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

1st Circuit Reverses Summary Judgment In Celexa/Lexapro Off-Label Suits

(January 31, 2019, 2:32 PM EST) -- BOSTON — The First Circuit U.S. Court of Appeals on Jan. 30 reversed summary judgment in an antidepressant off-label lawsuit but affirmed a trial court’s denial of class certification due to...
To view the full article, register now.